StrutzF., OkadaH., LoC.W., DanoffT., CaroneR.L., TomaszewskiJ.E., NeilsonE.G.. Identification and characterization of a fibroblast marker: FSP-1.J Cell Biol1995; 130: 393–405.
2.
RobertsA.B., AnzanoM.A., LambL.C., SmithJ.M., SpornM.B.. New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues.Proc Natl Acad Sci1981; 78: 5339–43.
3.
ChoiM.E.. Mechanism of transforming growth factor-ß1 signaling: role of the mitogen-activated protein kinase.Kidney Int2000; 58(Suppl): S53–8.
4.
RobertsA.B., PiekE., BottingerE.P., AshcroftG., MitchellJ.B., FlandersK.C.. Is smad3 a major player in signal transduction pathways leading to fibrogenesis.Chest2001; 120(Suppl): S43–7.
5.
HealyE., LeonardM., Madrigal-EstebasL., O'FarrellyC., WatsonA.J., RyanM.P.. Factors produced by activated leukocytes alter renal epithelial cell differentiation.Kidney Int1999; 56: 1266–9.
YamamotoT., NakamuraT., NobleN.A., RuoslahtiE., BorderW.A.. Expression of transforming growth factor ß is elevated in human and experimental diabetic nephropathy.Proc Natl Acad Sci1993; 90: 1814–8.
8.
OkudaS., LanguinoL.R., RuoslahtiE., BorderW.A.. Elevated expression of transforming growth factor-ß and proteoglycan production in experimental glomerulonephritis.J Clin Invest1990; 86: 453–62.
YangJ., LiuY.. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.Am J Pathol2001; 159: 1465–75.
11.
TianY.C., PhillipsA.O.. Interaction between the transforming growth factor-ß type II receptor/smad pathway and ß-catenin during transforming growth factor-ß1-mediated adherens junction disassembly.Am J Pathol2002; 160: 1619–28.
NightingaleJ., PatelS., SuzukiN., BuxtonR., TakagiK., SuzukiJ., SumiY., ImaizumiA., MasonR.M., ZhangZ., OncostatinM., A cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation.J Am Soc Nephrol2004, 15: 21–32.
14.
YoshiokaK., TakemuraT., MurakamiK., OkadaM., HinoS., MiyamotoH., MakiS.. Transforming growth factor-ß protein and mRNA in glomeruli in normal and diseased human kidneys.Lab Invest1993, 68: 154–63.
15.
SamR., WannaL., DuneaG., ArrudaJ.A., SinghA.K.. Transformation of glomerular epithelial cells into myofibroblasts with TGF-ß is reversible initially, but becomes permanent with continued stimulation (Abstract).J Am Soc Nephrol2003, 14: A123.
16.
AbbateM., ZojaC., MorigiM., RottoliD., AngiolettiS., TomasoniS., ZanchiC., LongarettiL., DonadelliR., RemuzziG.. Transforming growth factor-ß1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins.Am J Pathol2002, 161: 2179–93.
17.
BorderW.A., OkudaS., LanguinoL.R., SpornM.B., RuoslahtiE.. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor ß1.Nature1990, 346: 371–4.
18.
NiemirZ.I., SteinH., NoronhaI.L., KrugerC., AndrassyK., RitzE., WaldherrR.: PDGF and TGF-ß contribute to the natural course of human IgA glomerulonephritis.Kidney Int1995; 48: 1530–41.
19.
HayashidaT., PonceletA.C., HubchakS.C., SchnaperH.W.. TGF-ß1 activates MAP kinase in human mesangial cells: A possible role in collagen expression.Kidney Int1999; 56: 1710–20.
20.
YamamotoT., NobleN.A., CohenA.H., NastC.C., HishidaA., GoldL.I., BorderW.A.. Expression of transforming growth factor-ß isoforms in human glomerular diseases.Kidney Int1996; 49: 461–9.
21.
SchnaperH.W., HayashidaT., PonceletA.C.. It's smad world: Regulation of TGF-beta signaling in the kidney.J Am Soc Nephrol2002; 13: 1126–8.
22.
WadleE.N.. Renal fibrosis: Origin and potential of myofibroblasts.Nephron2002; 92: 880–2.
23.
GoumenosD.S., TsamandasA.C., NahasA.M.E., ThomasG., TsakasS., SotsiouF., BonikosD.S., VlachojannisJ.G.. Apoptosis and myofibroblast expression in human glomerular disease: A possible link with transforming growth factor-beta-1.Nephron2002; 92: 287–96.
24.
NgY.Y., FanJ.M., MuW., Nikolic-PatersonD.J., YangW.C., HuangT.P., AtkinR.C., LanH.Y.. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation.Nephrol Dial Transplant1999; 14: 2860–72.
25.
MoellerM.J., SoofiA., HartmannI., Le HirM., WigginsR., KrizW., HolzmanL.B.. Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis.J Am Soc Nephrol2004; 15: 61–7.
26.
JindeK., Nikolic-PatersonD.J., HuangX.R., SakaiH., KurokawaK., AtkinsR.C., LanH.Y.. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.Am J Kidney Dis2001; 38: 761–9.
IwanoM., PliethD., DanoffT.M., XueC., OkadaH., NeilsonE.G.. Evidence that fibroblasts derive form epithelium during tissue fibrosis.J Clin Invest2002; 110: 341–50.
29.
Yanez-MoM., Lara-PezziE., SelgasR., Ramirez-HuescaM., Dominguez-JimenezC., Jimenez-HeffermanJ.A., AguileraA., Sanchez-TomeroJ.A., BajoM.A., AlvarezV., CastroM.A., del PesoG., CirujedaA., GamalloC., Sanchez-MadridF., Lopez-CabreraM.. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.N Engl J Med2003; 348: 403–13.
30.
LiuY.. Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention.J Am Soc Nephrol2004; 15: 1–12.
31.
MartinJ., SteadmanR., KnowldenJ., WilliamsJ., DaviesM.. Differential regulation of matrix metalloproteinases and their inhibitors in human glomerular epithelial cells in vitro.J Am Soc Nephrol1998; 9: 1629–37.
32.
BoyerB., VallesA.M., EdmeN.. Induction and regulation of epithelial-mesenchymal transitions.Biochem Pharmacol2000; 60: 1091–9.
33.
YamashitaS., MaeshimaA., KojimaI., NojimaY.. Activin A is a potent activator of renal interstitial fibroblasts.J Am Soc Nephrol2004; 15: 91–101.
YueJ., MulderK.M.. Transforming growth factor-ß signal transduction in epithelial cells.Pharmacol Ther2001; 91: 1–34.
36.
DavidsonG., DonoR., ZellerR.. FGF signaling is required for differentiation-induced cytoskeletal reorganisation and formation of actin-based processes by podocytes.J Cell Sci2001; 114: 3359–66.
37.
StutzF., ZeisbergM., ZiyadehF.N., YangC.Q., KalluriR., MullerG.A., NeilsonE.G.. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation.Kidney Int2002; 61: 1714–28.
38.
KajiH., CanaffL., LebrunJ.J., GoltzmanD., HendyG.N.. Inactivation of menin, a smad3-interacting protein, blocks transforming growth factor type ß signaling.Proc Natl Acad Sci2001; 98: 3837–42.
39.
ItohS., ItohF., GoumansM.J., DijkeP.T.. Signaling of transforming growth factor-ß family members through smad proteins.Eur J Biochem2000; 267: 6954–67.
PonceletA.C., De CaesteckerM.P., SchnapperH.W.. The transforming growth factor-ß/smad pathway is present and functional in human mesangial cells.Kidney Int1999; 56: 1354–65.
43.
NicolasF.J., LehmannK., WarneP.H., HillC.S., DownwardJ.. Epithelial to mesenchymal transition in MDCK cells is accompanied by downregulation of smad3 expression leading to resistance to TGF-ß-induced growth arrest.J Biol Chem2003, 278: 3251–6.
44.
FujimotoM., MaezawaY., YokoteK., JohK., KobayashiK., KawamuraH., NishimuraM., RobertsA.B., SaitoY., MoriS.. Mice lacking smad3 are protected against Streptozotocin-induced diabetic glomerulopathy.Biochem Biophys Res Commun2003, 305: 1002–7.
45.
SatoM., MuragakiY., SaikaS., RobertsA.B., OoshimaA.. Targeted disruption of TGF-ß1/smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.J Clin Invest2003; 112: 1486–94.
46.
ChengS., LovettD.H.. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation.Am J Pathol2003; 162: 1937–49.
47.
LiY., YangJ., DaiC., WuC., LiuY.. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis.J Clin Invest2003; 112: 503–16.
48.
HayE.D., ZukA.. Transformations between epithelium and mesenchyme: Normal, pathological, and experimentally induced.Am J Kidney Dis1995; 26: 678–90.
